PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
A2M | Media Updates | 15:29 | 14K | 7.0M | |||
|
|||||||
A2M | Supply Side for A2M secured or not ? | 10:42 | 14 | 4.4K | |||
|
|||||||
A2M | Chart Update | 23/04/24 | 24K | 12M | |||
|
|||||||
A2M | New products released into Chinese market | 22/04/24 | 12 | 2.3K | |||
|
|||||||
A2M | Ann: Notification of cessation of securities - A2M | 19/04/24 | 17 | 3.9K | |||
|
|||||||
A2M | Synlait | 11/04/24 | 92 | 30K | |||
|
|||||||
A2M | Ann: Becoming a substantial holder | 05/04/24 | 1 | 754 | |||
|
|||||||
A2M | Ann: Becoming a substantial holder | 28/03/24 | 3 | 1.0K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |